Heparanase contributes to psoriatic lesions through crosstalk with IL-17 pathway

Psoriasis is a chronic inflammatory disease that is considered by a network of immunocytes and cytokines. Among all, Th17 cells-derived IL-17 is a critical driving factor in the pathogenesis of psoriasis. Recently, disruption of the extracellular matrix was found to be related to psoriasis progressi...

Full description

Saved in:
Bibliographic Details
Main Authors: Chengyao Zhu (Author), Yunqin Ren (Author), Hongliang Yao (Author), Bo Feng (Author), Lunfei Liu (Author), Min Zheng (Author)
Format: Book
Published: Wolters Kluwer Medknow Publications, 2023-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_8c31040d9bca4e95b37b7f1ddb95cc5c
042 |a dc 
100 1 0 |a Chengyao Zhu  |e author 
700 1 0 |a Yunqin Ren  |e author 
700 1 0 |a Hongliang Yao  |e author 
700 1 0 |a Bo Feng  |e author 
700 1 0 |a Lunfei Liu  |e author 
700 1 0 |a Min Zheng  |e author 
245 0 0 |a Heparanase contributes to psoriatic lesions through crosstalk with IL-17 pathway 
260 |b Wolters Kluwer Medknow Publications,   |c 2023-01-01T00:00:00Z. 
500 |a 0019-5154 
500 |a 1998-3611 
500 |a 10.4103/ijd.ijd_641_22 
520 |a Psoriasis is a chronic inflammatory disease that is considered by a network of immunocytes and cytokines. Among all, Th17 cells-derived IL-17 is a critical driving factor in the pathogenesis of psoriasis. Recently, disruption of the extracellular matrix was found to be related to psoriasis progression. In the present study, we aimed to investigate the role of heparanase (HPSE) in psoriasis and the crosstalk with the IL-17 signalling pathway. Skin tissues from non-affected areas and psoriatic lesion areas before and after 12 weeks of IL-17 monoclonal antibody treatment of 30 psoriasis patients were collected. HaCaT cells were treated with different concentrations of IL-17 antibody, and HPSE in cells and medium were measured with Western blotting assay as well as enzyme-linked immunosorbent assay (ELISA). In the imiquimod (IMQ)-induced psoriasis model, IL-17 protein and mRNA expression levels were measured, and changes in the proportion of Th17 cells were detected via flow cytometry. Our data showed that HPSE is upregulated in lesion tissues isolated from psoriasis patients, and was inhibited by anti-IL-17 treatment. In cutaneous cells and IMQ-induced psoriasis model, IL-17 promoted the synthesis of HPSE. Inversely, HPSE was also found to increase the percentage of Th17 cells derived from CD4+ T cells. Finally, we found that the combined treatments of HPSE inhibitor and IL-17 monoclonal antibody produced therapeutic effects on IMQ-induced psoriasis model. Our findings revealed the new role of HPSE in the pathogenesis of psoriasis and also provided a target for combined treatment of psoriasis. 
546 |a EN 
690 |a heparanase 
690 |a il-17 
690 |a psoriasis 
690 |a th17 cells 
690 |a Dermatology 
690 |a RL1-803 
655 7 |a article  |2 local 
786 0 |n Indian Journal of Dermatology, Vol 68, Iss 1, Pp 59-66 (2023) 
787 0 |n http://www.e-ijd.org/article.asp?issn=0019-5154;year=2023;volume=68;issue=1;spage=59;epage=66;aulast=Zhu 
787 0 |n https://doaj.org/toc/0019-5154 
787 0 |n https://doaj.org/toc/1998-3611 
856 4 1 |u https://doaj.org/article/8c31040d9bca4e95b37b7f1ddb95cc5c  |z Connect to this object online.